GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » Shiller PE Ratio

Moberg Pharma AB (OSTO:MOB) Shiller PE Ratio : 0.77 (As of May. 28, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB Shiller PE Ratio?

As of today (2024-05-28), Moberg Pharma AB's current share price is kr23.90. Moberg Pharma AB's E10 for the quarter that ended in Mar. 2024 was kr31.13. Moberg Pharma AB's Shiller PE Ratio for today is 0.77.

The historical rank and industry rank for Moberg Pharma AB's Shiller PE Ratio or its related term are showing as below:

OSTO:MOB' s Shiller PE Ratio Range Over the Past 10 Years
Min: 0.15   Med: 1.41   Max: 19.67
Current: 0.8

During the past years, Moberg Pharma AB's highest Shiller PE Ratio was 19.67. The lowest was 0.15. And the median was 1.41.

OSTO:MOB's Shiller PE Ratio is ranked better than
99.07% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.13 vs OSTO:MOB: 0.80

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Moberg Pharma AB's adjusted earnings per share data for the three months ended in Mar. 2024 was kr-0.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is kr31.13 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Moberg Pharma AB Shiller PE Ratio Historical Data

The historical data trend for Moberg Pharma AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Shiller PE Ratio Chart

Moberg Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.81 1.19 0.54 0.49

Moberg Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.20 0.21 0.49 0.73

Competitive Comparison of Moberg Pharma AB's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Shiller PE Ratio falls into.



Moberg Pharma AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Moberg Pharma AB's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=23.90/31.13
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moberg Pharma AB's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Moberg Pharma AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.23/132.2054*132.2054
=-0.230

Current CPI (Mar. 2024) = 132.2054.

Moberg Pharma AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 1.935 99.788 2.564
201406 1.879 100.432 2.473
201409 1.765 100.161 2.330
201412 -0.171 100.225 -0.226
201503 4.269 99.950 5.647
201506 2.163 99.995 2.860
201509 3.472 100.228 4.580
201512 0.000 100.276 0.000
201603 -2.277 100.751 -2.988
201606 11.157 101.019 14.601
201609 5.066 101.138 6.622
201612 -1.139 102.022 -1.476
201703 -0.968 102.022 -1.254
201706 -2.562 102.752 -3.296
201709 4.042 103.279 5.174
201712 3.131 103.793 3.988
201803 0.683 103.962 0.869
201806 1.537 104.875 1.938
201809 0.683 105.679 0.854
201812 3.586 105.912 4.476
201903 181.877 105.886 227.085
201906 19.926 106.742 24.679
201909 10.019 107.214 12.354
202003 -1.159 106.563 -1.438
202006 -1.802 107.498 -2.216
202009 -1.609 107.635 -1.976
202012 -2.189 108.296 -2.672
202103 3.025 108.360 3.691
202106 -0.533 108.928 -0.647
202109 -0.600 110.338 -0.719
202112 -0.667 112.486 -0.784
202203 -0.667 114.825 -0.768
202206 -0.413 118.384 -0.461
202209 -0.430 122.296 -0.465
202212 -0.230 126.365 -0.241
202303 -0.510 127.042 -0.531
202306 -0.260 129.407 -0.266
202309 -0.360 130.224 -0.365
202312 -0.230 131.912 -0.231
202403 -0.230 132.205 -0.230

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Moberg Pharma AB  (OSTO:MOB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Moberg Pharma AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Moberg Pharma AB (OSTO:MOB) Business Description

Traded in Other Exchanges
Address
Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.